Literature DB >> 156366

Down syndrome: gene dosage at the transcriptional level in skin fibroblasts.

D M Kurnit.   

Abstract

Chromosome imbalance (aneusomy) is the leading known cause of both spontaneous abortion and mental retardation in human beings. The primary abnormality is thought to result from quantitative changes of transcription products from the unbalanced genetic material. To document this point, I compared chromosome 21-specific transcription in skin fibroblasts from subjects with monosomy 21, disomy 21 (normal), and trisomy 21 (Down syndrome). Polyadenylylated RNA [poly(A)-RNA], which is enriched in messenger and messenger-precursor RNA sequences, was isolated from the above fibroblast lines. Radioactive DNA (cDNA) complementary to these RNAs was synthesized with reverse transcriptase (RNA-dependent DNA polymerase). These cDNAs were hybridized with (i) DNA from a cell line with a mouse genome plus human chromosome 21 and (ii) mouse DNA. Subtraction of the amount of hybridization in experiment ii from that in experiment i yielded a measure of human chromosome 21-specific RNA sequences. The results were consistent with gene dosage at the transcriptional level; for monosomy 21-derived cDNA, 0.6% (of the total cDNA) hybridized specifically to human chromosome 21; for disomy 21-derived cDNA, 2% hybridized; and for trisomy 21-derived cDNA, 3% hybridized. Thus, for DNA sequences on chromosome 21 in human skin fibroblasts, transcription depends on DNA dosage. Characterization of the chromosome 21-specific RNA sequences quantitated in these experiments could help to elucidate the mechanisms by which abnormal karyotypes result in abnormal phenotypes.

Entities:  

Mesh:

Year:  1979        PMID: 156366      PMCID: PMC383603          DOI: 10.1073/pnas.76.5.2372

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  43 in total

1.  Types of enzymatic overdosing in trisomy 21: erythrocytic superoxide dismutase-AJ and phosphoglucomutase.

Authors:  R Prişcu; S Sichitiu
Journal:  Humangenetik       Date:  1975-08-29

2.  Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat.

Authors:  M Rosbash; M S Campo; K S Gummerson
Journal:  Nature       Date:  1975-12-25       Impact factor: 49.962

3.  Retrospective and prospective epidemiological studies of 1500 karyotyped spontaneous human abortions.

Authors:  J Boué; P Lazar
Journal:  Teratology       Date:  1975-08

4.  SEDIMENTATION STUDIES OF THE SIZE AND SHAPE OF DNA.

Authors:  F W STUDIER
Journal:  J Mol Biol       Date:  1965-02       Impact factor: 5.469

5.  [Contribution to the study of monogoloid twins. A case of heterokaryotic monozygotism].

Authors:  K SCHARER; J LEJEUNE
Journal:  Helv Paediatr Acta       Date:  1962

6.  A singular dermatosis of Mongols.

Authors:  O A Finn; P W Grant; D I McCallum; E J Raffle
Journal:  Arch Dermatol       Date:  1978-10

7.  An objective in vitro study of ageing in the skin of patients with Down's syndrome.

Authors:  J C Murdoch; J H Evans
Journal:  J Ment Defic Res       Date:  1978-06

8.  The expression of three abundance classes of messenger RNA in mouse tissues.

Authors:  N D Hastie; J O Bishop
Journal:  Cell       Date:  1976-12       Impact factor: 41.582

9.  Dosage effects for superoxide dismutase-1 in nucleated cells aneuploid for chromosome 21.

Authors:  W W Feaster; L W Kwok; C J Epstein
Journal:  Am J Hum Genet       Date:  1977-11       Impact factor: 11.025

10.  Influence of homoeologous chromosomes on gene-dosage effects in allohexaploid wheat (Triticum aestivum L.).

Authors:  C Aragoncillo; M A Rodríguez-Loperena; G Salcedo; P Carbonero; F García-Olmedo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-03       Impact factor: 11.205

View more
  14 in total

1.  Comparison of total cellular DNA, mRNA, and rRNA levels between normals and Down syndrome patients.

Authors:  C I McQuillan; K H Choo
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

Review 2.  New insights into the troubles of aneuploidy.

Authors:  Jake J Siegel; Angelika Amon
Journal:  Annu Rev Cell Dev Biol       Date:  2012-07-09       Impact factor: 13.827

3.  Alterations in the relative amounts of specific mRNA species in the developing human brain in Down's syndrome.

Authors:  S A Whatley; C Hall; A N Davison; L Lim
Journal:  Biochem J       Date:  1984-05-15       Impact factor: 3.857

4.  Increased adhesiveness of Down syndrome fetal fibroblasts in vitro.

Authors:  T C Wright; R W Orkin; M Destrempes; D M Kurnit
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

5.  Intraocular pathology of trisomy 18 (Edwards's syndrome): report of a case and review of the literature.

Authors:  J P Calderone; J Chess; G Borodic; D M Albert
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

Review 6.  Short- and long-term effects of chromosome mis-segregation and aneuploidy.

Authors:  Stefano Santaguida; Angelika Amon
Journal:  Nat Rev Mol Cell Biol       Date:  2015-08       Impact factor: 94.444

7.  Nucleotide sequence and expression of human chromosome 21-encoded superoxide dismutase mRNA.

Authors:  L Sherman; N Dafni; J Lieman-Hurwitz; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

8.  Demonstration, by somatic cell genetics, of coordinate regulation of genes for two enzymes of purine synthesis assigned to human chromosome 21.

Authors:  D Patterson; S Graw; C Jones
Journal:  Proc Natl Acad Sci U S A       Date:  1981-01       Impact factor: 11.205

9.  Human cytoplasmic superoxide dismutase cDNA clone: a probe for studying the molecular biology of Down syndrome.

Authors:  J Lieman-Hurwitz; N Dafni; V Lavie; Y Groner
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

10.  Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome.

Authors:  Chan-Kyung J Cho; Andrei P Drabovich; George S Karagiannis; Eduardo Martínez-Morillo; Shawn Dason; Apostolos Dimitromanolakis; Eleftherios P Diamandis
Journal:  Clin Proteomics       Date:  2013-02-08       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.